JPMorgan Chase & Co’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,111
Closed -$1.47K 6681
2024
Q3
$1.47K Buy
1,111
+107
+11% +$141 ﹤0.01% 5606
2024
Q2
$7.63K Hold
1,004
﹤0.01% 5300
2024
Q1
$9.04K Hold
1,004
﹤0.01% 5352
2023
Q4
$10.8K Hold
1,004
﹤0.01% 5365
2023
Q3
$6.09K Buy
1,004
+1,003
+100,300% +$6.09K ﹤0.01% 5398
2023
Q2
$9 Hold
1
﹤0.01% 5915
2023
Q1
$0 Hold
1
﹤0.01% 6232
2022
Q4
$0 Hold
1
﹤0.01% 6079
2022
Q3
$0 Hold
1
﹤0.01% 5940
2022
Q2
$0 Sell
1
-1,038
-100% ﹤0.01% 6024
2022
Q1
$29K Sell
1,039
-15
-1% -$419 ﹤0.01% 5189
2021
Q4
$48K Sell
1,054
-996
-49% -$45.4K ﹤0.01% 5091
2021
Q3
$171K Buy
2,050
+1,200
+141% +$100K ﹤0.01% 4484
2021
Q2
$81K Buy
850
+838
+6,983% +$79.9K ﹤0.01% 4831
2021
Q1
$2K Buy
+12
New +$2K ﹤0.01% 5175
2020
Q4
Hold
0
5167
2020
Q3
Hold
0
5088
2020
Q2
Hold
0
5019
2019
Q4
Sell
-3
Closed 4916
2019
Q3
$0 Buy
+3
New ﹤0.01% 4951
2019
Q2
Sell
-9
Closed -$1K 4985
2019
Q1
$1K Sell
9
-41
-82% -$4.56K ﹤0.01% 4795
2018
Q4
$5K Buy
50
+42
+525% +$4.2K ﹤0.01% 4712
2018
Q3
$2K Sell
8
-30
-79% -$7.5K ﹤0.01% 4767
2018
Q2
$82K Buy
+38
New +$82K ﹤0.01% 4148
2018
Q1
Sell
-7
Closed -$12K 4818
2017
Q4
$12K Sell
7
-22
-76% -$37.7K ﹤0.01% 4474
2017
Q3
$35K Buy
+29
New +$35K ﹤0.01% 3875